beta-1,4-N-Acetylgalactosaminyltransferase (CgtA), CAS 67338-98-1

Product Description: beta-1,4-N-Acetylgalactosaminyltransferase (CgtA) (GM2/GD2 synthase) is a key enzyme which catalyzes the conversion of GM3, GD3 and lactosylceramide (LacCer) to GM2, GD2 and asialo-GM2 (GA2), respectively. beta-1,4-N-Acetylgalactosaminyltransferase (CgtA) is a key enzyme to control the synthesis of brain-enriched complex gangliosides[1].

Applications: Neuroscience-Neuromodulation

Formula: N/A

References: [1]Furukawa K, et al. Beta1,4-N-acetylgalactosaminyltransferase--GM2/GD2 synthase: a key enzyme to control the synthesis of brain-enriched complex gangliosides. Biochim Biophys Acta. 2002 Dec 19;1573(3):356-62.

CAS Number: 67338-98-1

Molecular Weight: N/A

Research Area: Neurological Disease

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-E70049-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-E70049-1
• Green Labware: Nein
• Verpackungseinheit: 1U
• Mengeneinheit: STK